Base de dados : MEDLINE
Pesquisa : L01.178.682.192.836.535.561 [Categoria DeCS]
Referências encontradas : 891 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 90 ir para página                         

  1 / 891 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28776442
[Au] Autor:Matlala M; Gous AG; Godman B; Meyer JC
[Ad] Endereço:a School of Pharmacy , Sefako Makgatho Health Sciences University , Pretoria , South Africa.
[Ti] Título:Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications.
[So] Source:Expert Rev Clin Pharmacol;10(11):1273-1280, 2017 Nov.
[Is] ISSN:1751-2441
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:INTRODUCTION: The WHO identified Pharmacy and Therapeutics Committees (PTCs) as a pivotal model to promote rational medicine use in hospitals. This matches a key South African (SA) government objective to establish PTCs in all hospitals to ensure rational, efficient and cost-effective use of medicines. However, documentation on the functionality of PTCs in public hospitals in SA is limited. Areas covered: This study aimed to address this. A 3-phased mixed methods approach involving questionnaires, observations of PTC meetings and semi-structured interviews was used. The findings were converged during the interpretation phase. Expert commentary: Most professionals were represented in the PTCs, with variations across hospitals. Membership of PTCs included a pharmacist, who in the majority of cases was the secretary. PTC activities included dissemination of decisions (100%) and formulary management (89.5%). However, reporting of adverse drug reactions (ADRs) and medication errors was typically poor at all hospital levels. Lack of expertise of pharmacoeconomic analysis and evidence-based decision-making in formulary management was identified as a key challenge in formulary management. In conclusion, future programmes should strengthen PTCs in specialised aspects of formulary management. Further training in the principles of pharmacovigilance is needed to enhance ADR reporting, as well as to ensure compliance with both WHO and provincial guidelines.
[Mh] Termos MeSH primário: Hospitais Públicos/organização & administração
Farmacêuticos/organização & administração
Serviço de Farmácia Hospitalar/organização & administração
Comitê de Farmácia e Terapêutica/organização & administração
[Mh] Termos MeSH secundário: Sistemas de Notificação de Reações Adversas a Medicamentos
Tomada de Decisões
Formulários de Hospitais
Seres Humanos
Erros de Medicação
Papel Profissional
África do Sul
Inquéritos e Questionários
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171108
[Lr] Data última revisão:
171108
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170805
[St] Status:MEDLINE
[do] DOI:10.1080/17512433.2017.1364625


  2 / 891 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28246338
[Au] Autor:Larose G; Levy A; Bailey B; Cummins-McManus B; Lebel D; Gravel J
[Ad] Endereço:Division of Emergency Medicine, Department of Pediatrics and guylainelarose@gmail.com.
[Ti] Título:Decreasing Prescribing Errors During Pediatric Emergencies: A Randomized Simulation Trial.
[So] Source:Pediatrics;139(3), 2017 Mar.
[Is] ISSN:1098-4275
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: To evaluate whether a clinical aid providing precalculated medication doses decreases prescribing errors among residents during pediatric simulated cardiopulmonary arrest and anaphylaxis. METHODS: A crossover randomized trial was conducted in a tertiary care hospital simulation center with residents rotating in the pediatric emergency department. The intervention was a reference book providing weight-based precalculated doses. The control group used a card providing milligram-per-kilogram doses. The primary outcome was the presence of a prescribing error, defined as a dose varying by ≥20% from the recommended dose or by incorrect route. Residents were involved in 2 sets of paired scenarios and were their own control group. Primary analysis was the difference in mean prescribing error proportions between both groups. RESULTS: Forty residents prescribed 1507 medications or defibrillations during 160 scenarios. The numbers of prescribing errors per 100 bolus medications or defibrillations were 5.1 (39 out of 762) and 7.5 (56 out of 745) for the intervention and control, respectively, a difference of 2.4 (95% confidence interval [CI], -0.1 to 5.0). However, the intervention was highly associated with lower risk of 10-fold error for bolus medications (odds ratio 0.27; 95% CI, 0.10 to 0.70). For medications administered by infusion, prescribing errors occurred in 3 out of 76 (4%) scenarios in the intervention group and 13 out of 76 (22.4%) in the control group, a difference of 13% (95% CI, 3 to 23). CONCLUSIONS: A clinical aid providing precalculated medication doses was not associated with a decrease in overall prescribing error rates but was highly associated with a lower risk of 10-fold error for bolus medications and for medications administered by continuous infusion.
[Mh] Termos MeSH primário: Cálculos da Dosagem de Medicamento
Serviço Hospitalar de Emergência
Formulários de Hospitais
Erros de Medicação/prevenção & controle
[Mh] Termos MeSH secundário: Adulto
Anafilaxia/tratamento farmacológico
Estudos Cross-Over
Cardioversão Elétrica
Medicina de Emergência/educação
Feminino
Seres Humanos
Internato e Residência
Masculino
Manequins
Erros de Medicação/estatística & dados numéricos
Pediatria/educação
Quebeque
Treinamento por Simulação
Taquicardia Ventricular/terapia
Fibrilação Ventricular/terapia
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
[Em] Mês de entrada:1706
[Cu] Atualização por classe:171111
[Lr] Data última revisão:
171111
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170302
[St] Status:MEDLINE


  3 / 891 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28045652
[Au] Autor:Vázquez-Mourelle R; Carracedo-Martínez E
[Ad] Endereço:Assistant Manager. Galician Health Service. Xunta de Galicia. Santiago de Compostela, Galicia. Spain.. raquel.vazquez.mourelle@sergas.es.
[Ti] Título:The influence of changes in hospital drug formulary on the prescription of proton pump inhibitors.
[Ti] Título:Influencia del cambio de la guía farmacoterapéutica hospitalaria en la prescripción de inhibidores de la bomba de protones..
[So] Source:Farm Hosp;41(n01):49-67, 2017 Jan 01.
[Is] ISSN:0214-753X
[Cp] País de publicação:Spain
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: To analyze the impact of introducing omeprazole in the drug formulary of the Hospital de Barbanza on prescriptions made in hospital and out-of-hospital (Outpatient Units and Primary Care) for all Proton Pump Inhibitors (PPIs). MATERIAL AND METHODS: A 36-month retrospective descriptive study in a level I hospital. The basic units of work are Dose-Population- Day in the outpatient setting, and the Defined Daily Dose/stays-day for hospitalized patients; the proportion of DDDs for omeprazole vs. the rest of PPIs is used as measure of efficiency. For statistical analysis, we built a segmented regression model. RESULTS: In the outpatient units, there are statistically significant changes for pantoprazole and rabeprazole. The first drug, which was stable before the intervention, suffered an immediate decrease; rabeprazole, which was increasing before the intervention, presented a subsequent downward trend. In Primary Care, a statistically significant change was confirmed for pantoprazole, with a long-term decreasing trend. In hospitalization, statistically significant changes were observed for pantoprazole and omeprazole; the first one with an immediate decrease and a long-term tendency to decrease, while omeprazole experienced an immediate increase and long-term growth. The evolution of the omeprazole percentage vs. all PPIs showed increases in all three scenarios. CONCLUSIONS: A shift to a more efficient prescription of PPIs was observed in all healthcare settings following the introduction of omeprazole in the hospital drug formulary. The inclusion of efficient drugs, or the removal of those inefficient, can be a potentially useful tool in order to improve prescription profiles.
[Mh] Termos MeSH primário: Formulários de Hospitais
Inibidores da Bomba de Prótons/uso terapêutico
[Mh] Termos MeSH secundário: 2-Piridinilmetilsulfinilbenzimidazóis
Prescrições de Medicamentos/estatística & dados numéricos
Uso de Medicamentos
Seres Humanos
Omeprazol/uso terapêutico
Pacientes Ambulatoriais
Estudos Retrospectivos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (2-Pyridinylmethylsulfinylbenzimidazoles); 0 (Proton Pump Inhibitors); D8TST4O562 (pantoprazole); KG60484QX9 (Omeprazole)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171023
[Lr] Data última revisão:
171023
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170104
[St] Status:MEDLINE
[do] DOI:10.7399/fh.2017.41.1.10559


  4 / 891 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27668562
[Au] Autor:Nimbal V; Segal JB; Romanelli RJ
[Ad] Endereço:1 Palo Alto Medical Foundation Research Institute, Palo Alto, California.
[Ti] Título:Estimating Generic Drug Use with Electronic Health Records Data from a Health Care Delivery System: Implications for Quality Improvement and Research.
[So] Source:J Manag Care Spec Pharm;22(10):1143-7, 2016 Oct.
[Is] ISSN:2376-1032
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Generic drug use in the outpatient setting is typically measured with adjudicated pharmacy claims; however, not all delivery systems have access to these data for their clinical populations. OBJECTIVE: To develop an algorithm to estimate generic drug use in an outpatient setting using electronic health records (EHR) data. METHODS: Twenty-five therapeutic classes were chosen with the potential for low generic use that were prescribed to managed care beneficiaries in a health care system in Northern California. An algorithm was developed to estimate generic drug use based on medication names and dispense-as-written requests from electronic prescriptions, as well as information on generic availability at the time the prescriptions were written. The algorithm was used to quantify a generic utilization rate (GUR) across therapeutic classes and was validated by comparing the estimated GUR to the true GUR, using pharmacy claims corresponding to prescriptions in the same patient cohort. RESULTS: Among managed care beneficiaries, 104,859 prescriptions were identified for drugs in the therapeutic classes of interest with corresponding pharmacy claims. The algorithm estimated a GUR of 73.7% across 25 unique classes. The actual GUR based on pharmacy claims was 73.1%. Sensitivity (97%) and specificity (89%) of the algorithm were high, and total percentage of agreement was 95%. CONCLUSIONS: An algorithm that estimates generic drug use performed well in a population of managed care beneficiaries. Health care delivery systems may apply methods described in this article to quantify generic drug use in their ambulatory populations for quality improvement and research initiatives, particularly when pharmacy claims are unavailable. DISCLOSURES: This study was funded by a grant from the U.S. Food and Drug Administration in cooperative agreement with the Johns Hopkins School of Medicine and the Palo Alto Medical Foundation Research Institute (1U01FD005267-01). Romanelli has received research grant support from Pfizer and Janssen Scientific Affairs. Authors have no other conflicts to disclose. Romanelli and Segal contributed the study concept and design. Nimbal took the lead in data collection, assisted by Romanelli. All authors were involved with data interpretation and revision of the manuscript. The manuscript was written by Romanelli and Nimbal.
[Mh] Termos MeSH primário: Algoritmos
Uso de Medicamentos/estatística & dados numéricos
Medicamentos Genéricos
Registros Eletrônicos de Saúde
[Mh] Termos MeSH secundário: Adulto
Idoso
Idoso de 80 Anos ou mais
California
Feminino
Formulários de Hospitais
Seres Humanos
Masculino
Programas de Assistência Gerenciada
Meia-Idade
Pacientes Ambulatoriais
Melhoria de Qualidade
Pesquisa
Sensibilidade e Especificidade
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Drugs, Generic)
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170809
[Lr] Data última revisão:
170809
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160927
[St] Status:MEDLINE
[do] DOI:10.18553/jmcp.2016.22.10.1143


  5 / 891 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27579827
[Au] Autor:Britt RB; Hashem MG; Bryan WE; Kothapalli R; Brown JN
[Ad] Endereço:1 Durham VA Medical Center, Durham, North Carolina.
[Ti] Título:Economic Outcomes Associated with a Pharmacist-Adjudicated Formulary Consult Service in a Veterans Affairs Medical Center.
[So] Source:J Manag Care Spec Pharm;22(9):1051-61, 2016 Sep.
[Is] ISSN:2376-1032
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Several cost analysis studies have been conducted looking at clinical and economic outcomes associated with clinical pharmacist services in a variety of health care settings. However, there is a paucity of data regarding the economic impact of clinical pharmacist involvement in formulary management at the hospital level. OBJECTIVE: To evaluate economic outcomes of a pharmacist-adjudicated formulary management consult service in a Veterans Affairs (VA) medical center offering outpatient and inpatient services. METHODS: This VA medical center uses a pharmacist-adjudicated formulary management system for review of restricted drug consults. A retrospective review of electronic medical records was conducted to identify restricted drug consults at this institution between January 1, 2014, and March 31, 2014. Only restricted drug consults that were not approved were included for evaluation in order to best characterize the effects of formulary interventions by pharmacists. Economic outcomes were determined as direct cost savings by comparing the cost of requested drug with the recommended drug and accounting for the cost of pharmacist review. Characteristics of consults that were not approved and pharmacist rationale were also evaluated. RESULTS: Of 1,802 restricted drug consults adjudicated by a pharmacist during the study period, 198 consults in 190 individual patients met criteria for inclusion and were evaluated. The most commonly requested indications were dyslipidemia, pain, and diabetes, while the most commonly requested drugs were rosuvastatin, insulin pens, tamsulosin, varenicline, ezetimibe, and rivaroxaban. The majority of consults were requested for outpatient use. Total cost savings among 195 evaluable consults was $420,324.05, while mean cost savings per consult was $2,229.43 (range: -$3,009.27-$65,982.36). The highest cost savings were seen with outpatient use. CONCLUSIONS: A pharmacist-adjudicated formulary consult service in a VA medical center was associated with a substantial cost savings after adjustment for cost of pharmacist review. Future research should assess clinical outcomes associated with a restrictive formulary management system. DISCLOSURES: No outside funding supported this study. None of the authors report any financial interests or potential conflict of interest with regard to this work. Study concept and design were created by all authors. Data were collected and interpreted by Britt, with input from all authors. The manuscript was written by Britt and revised by all authors.
[Mh] Termos MeSH primário: Redução de Custos/economia
Custos de Medicamentos
Formulários de Hospitais
Hospitais de Veteranos/economia
Farmacêuticos
Encaminhamento e Consulta/economia
[Mh] Termos MeSH secundário: Adulto
Idoso
Idoso de 80 Anos ou mais
Redução de Custos/métodos
Redução de Custos/tendências
Custos de Medicamentos/tendências
Feminino
Hospitais de Veteranos/tendências
Seres Humanos
Masculino
Meia-Idade
Farmacêuticos/tendências
Encaminhamento e Consulta/tendências
Estudos Retrospectivos
Veteranos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1704
[Cu] Atualização por classe:170428
[Lr] Data última revisão:
170428
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160901
[St] Status:MEDLINE
[do] DOI:10.18553/jmcp.2016.22.9.1051


  6 / 891 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27036539
[Au] Autor:Freyer G; Marty M; Blay JY; Chauffert B; Ganem G; Lotz JP; Marchal F; Medioni J; Ray-Coquard I; membres du groupe de travail
[Ad] Endereço:Institut de cancérologie, hospices civils de Lyon, 165, chemin du Grand-Revoyet, 69310 Pierre-Bénite, France. Electronic address: gilles-freyer@univ-lyon1.fr.
[Ti] Título:[Innovative anticancer agents reserved to hospital use and not involved in the hospital budget: Creation and evolution].
[Ti] Título:La liste en sus de la tarification à l'activité pour les agents anticancéreux : genèse et évolution..
[So] Source:Bull Cancer;103(4):315-7, 2016 Apr.
[Is] ISSN:1769-6917
[Cp] País de publicação:France
[La] Idioma:fre
[Mh] Termos MeSH primário: Antineoplásicos/uso terapêutico
Orçamentos
Formulários de Hospitais
[Mh] Termos MeSH secundário: Economia Hospitalar
Seres Humanos
[Pt] Tipo de publicação:EDITORIAL
[Nm] Nome de substância:
0 (Antineoplastic Agents)
[Em] Mês de entrada:1609
[Cu] Atualização por classe:160422
[Lr] Data última revisão:
160422
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160403
[St] Status:MEDLINE


  7 / 891 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27001376
[Au] Autor:Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP
[Ad] Endereço:Pharmacy & Therapeutics Office,Group Corporate Development,National Healthcare GroupMonica_Teng@nhg.com.sg.
[Ti] Título:INTEGRATING HEALTH TECHNOLOGY ASSESSMENT PRINCIPLES IN FORMULARY MANAGEMENT.
[So] Source:Int J Technol Assess Health Care;32(1-2):81-7, 2016 Jan.
[Is] ISSN:1471-6348
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:OBJECTIVES: Effective formulary management in healthcare institutions safeguards rational drug use and optimizes health outcomes. We implemented a formulary management program integrating the principles of health technology assessment (HTA) to improve the safe, appropriate, and cost-effective use of medicine in Singapore. METHODS: A 3-year formulary management program was initiated in 2011 in five public healthcare institutions. This program was managed by a project team comprising HTA researchers. The project team worked with institutional pharmacy and therapeutics (P&T) committees to: (i) develop tools for formulary drug review and decision making; (ii) enhance the HTA knowledge and skills of formulary pharmacists and members of P&T committees; (iii) devise a prioritization framework to overcome resource constraints and time pressure; and (iv) conceptualize and implement a framework to review existing formulary. RESULTS: Tools that facilitate drug request submission, drug review, and decision making were developed for formulary drug inclusion. A systematic framework to review existing formulary was also developed and tested in selected institutions. A competency development plan was rolled out over 2 years to enhance formulary pharmacists' proficiency in systematic literature search and review, meta-analysis, and pharmacoeconomic evaluation. The plan comprised training workshops and on-the-job knowledge transfer between the project team and institutional formulary pharmacists through collaborating on selected drug reviews. A resource guide that consolidated the tools and templates was published to encourage the adoption of best practices in formulary management. CONCLUSIONS: Based on the concepts of HTA, we implemented an evidence-based approach to optimize formulary management.
[Mh] Termos MeSH primário: Tomada de Decisões
Custos de Medicamentos
Formulários de Hospitais
Comitê de Farmácia e Terapêutica/organização & administração
Avaliação da Tecnologia Biomédica/organização & administração
[Mh] Termos MeSH secundário: Seres Humanos
Capacitação em Serviço
Farmacêuticos/organização & administração
Singapura
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1705
[Cu] Atualização por classe:170531
[Lr] Data última revisão:
170531
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160323
[St] Status:MEDLINE
[do] DOI:10.1017/S0266462316000040


  8 / 891 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26843491
[Au] Autor:Traynor K
[Ti] Título:Hospital pharmacies cope with surge in drug prices.
[So] Source:Am J Health Syst Pharm;73(4):182-4, 2016 Feb 15.
[Is] ISSN:1535-2900
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Custos de Medicamentos
Formulários de Hospitais
Serviço de Farmácia Hospitalar/organização & administração
[Mh] Termos MeSH secundário: Indústria Farmacêutica/economia
Seres Humanos
Nitroprussiato/economia
Serviço de Farmácia Hospitalar/economia
[Pt] Tipo de publicação:NEWS
[Nm] Nome de substância:
169D1260KM (Nitroprusside)
[Em] Mês de entrada:1610
[Cu] Atualização por classe:161230
[Lr] Data última revisão:
161230
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160205
[St] Status:MEDLINE
[do] DOI:10.2146/news160012


  9 / 891 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26683678
[Au] Autor:Her QL; Seger DL; Amato MG; Beeler PE; Dalleur O; Slight SP; Dykes PC; Bates DW
[Ad] Endereço:Qoua L. Her, Pharm.D., M.S., M.Sc., is Pharmacy Informatics and Outcomes Research Fellow, MCPHS University School of Pharmacy-Boston and Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital (BWH), Boston, MA. Diane L. Seger, B.S.Pharm., is Senior Pharmaco-Informatics
[Ti] Título:Development of an algorithm to assess appropriateness of overriding alerts for nonformulary medications in a computerized prescriber-order-entry system.
[So] Source:Am J Health Syst Pharm;73(1):e34-45, 2016 Jan 01.
[Is] ISSN:1535-2900
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:PURPOSE: An algorithm for assessing the appropriateness of physician overrides of clinical decision support alerts triggered by nonformulary medication (NFM) requests is described. METHODS: Data on a random sample of 5000 NFM alert overrides at Brigham and Women's Hospital over a four-year period (2009-12) were extracted from the hospital's computerized prescriber-order-entry (CPOE) system. Through an iterative process, a scheme for categorizing the reasons given by prescribers for alert overrides was developed. A pharmacist and a physician used the categorization scheme to classify and group alert override reasons, and the resultant data guided the development of an algorithm for assessing alert overrides. RESULTS: In free-text comments written in response to NFM alerts, prescribers provided more than 1150 unique reasons to justify formulary deviation. The compiled reasons were analyzed and grouped into nine categories through the iterative process, with a high degree of interrater agreement (κ = 0.989; 95% confidence interval, 0.985-0.992). An initially developed 30-item "NFM alert override appropriateness algorithm" was simplified to create an 8-question algorithm that was presented to an interdisciplinary team for evaluation, with subsequent refinements for enhanced clinical creditability. The final algorithm can be used by researchers and formulary managers to develop strategies for limiting NFM alert overrides and to avoid the labor-intensive task of creating appropriateness criteria for each NFM. CONCLUSION: A multistep process was used to develop a generalized algorithm for categorizing the appropriateness of reasons given for NFM alert overrides in a CPOE system.
[Mh] Termos MeSH primário: Algoritmos
Quimioterapia Assistida por Computador/normas
Formulários de Hospitais/normas
Sistemas de Registro de Ordens Médicas/normas
Erros de Medicação/prevenção & controle
[Mh] Termos MeSH secundário: Sistemas de Apoio a Decisões Clínicas/normas
Quimioterapia Assistida por Computador/métodos
Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1609
[Cu] Atualização por classe:151219
[Lr] Data última revisão:
151219
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:151220
[St] Status:MEDLINE
[do] DOI:10.2146/ajhp150156


  10 / 891 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
[PMID]:26399145
[Au] Autor:Seguí Puntas MG; Carmona Cornet AM
[Ti] Título:[Brief notice of the presentation of a book presentation: Surgical formulary for use in the Military Hospital of Mahón].
[Ti] Título:Breve reseña de la presentación del libro: Formulario cirujíco para uso del Hospital Militar de Mahón..
[So] Source:Med Hist (Barc);(2):41-2, 2015.
[Is] ISSN:0300-8169
[Cp] País de publicação:Spain
[La] Idioma:spa
[Mh] Termos MeSH primário: Formulários de Hospitais/história
Hospitais Militares
[Mh] Termos MeSH secundário: História do Século XVIII
História do Século XIX
Espanha
[Pt] Tipo de publicação:HISTORICAL ARTICLE; JOURNAL ARTICLE
[Em] Mês de entrada:1510
[Cu] Atualização por classe:150924
[Lr] Data última revisão:
150924
[Sb] Subgrupo de revista:QIS
[Da] Data de entrada para processamento:150925
[St] Status:MEDLINE



página 1 de 90 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde